WHO ICTRP trial
EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE…
CTIS2024-515255-38-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-515255-38-00 |
|---|---|
| Public title | EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) |
| Scientific title | EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL) - EMBRACE |
| Primary sponsor | Hellenic Institute For The Study Of Sepsis |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Greece |
| Conditions | SEPSIS;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01];Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08];Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Product Name: EMAPALUMAB, Product Code:SUB188645, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Sodium Chloride Injection/ DEMO 0,9% w/v, Product Code:PRD355723, Pharmaceutical Form… |
| Registration date | Feb 7, 2024 |
| Target size | 75 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: